Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
What each said, in their own words
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
Compagnie nationale des agents en propriété industrielle (CNCPI) is the French official body comprising all industrial property agents, namely the liberal professionals specialising in industrial property operating in France. In the context of the public consultation on the European Biotech Act, the CNCPI wishes to bring the attached position paper to the attention of the European Commission.
Filed in French · English published by the European Commission
The Association welcomes the European Biotech Act I and strongly supports the objective of making Europe the world’s most attractive location for research, development, clinical trials, manufacturing and scaling of biotech innovations. It is crucial to create a coherent, reliable and internationally competitive framework along the entire value chain.
Filed in German · English published by the European Commission
The CNCPI, a body set up by the French Intellectual Property Code and representing the regulated liberal profession of all French patent agents, thanked the European Commission for the opportunity to participate in this call for contributions and welcomed its willingness to consult with a view to possible legislative work on compulsory patent licences.
Filed in French · English published by the European Commission
The current very robust intellectual property protection system (SGE) in the EU has made it possible to invest significantly in research to develop novel AM (AM) and vaccines, including those to fight COVID-19. The SGE has put in place the legal framework and incentives to do so. This formed the basis for countless cooperation that was and is necessary for the entry into the trade mark.
Filed in German · English published by the European Commission
The FCIO welcomes the harmonisation of patent law, which focuses on the granting of compulsory licences. Where supply chains cannot provide necessary services/goods in the event of a crisis, government corrective instruments will be supported. However, such an instrument must not pursue other purposes outside crisis management in Europe’s internal market (e.g. forced technology transfers).
Filed in German · English published by the European Commission
The CNCPI, a body representing the regulated liberal profession comprising all French patent agents, thanks the European Commission for the opportunity to participate in this call for contributions and welcomes its desire to review the system for granting supplementary protection certificates (SPCs).
Filed in French · English published by the European Commission
The supply of innovative products such as pharmaceuticals and plant protection products is a complex, time-consuming and financially risky process. The patent system guarantees investment protection in return for the provision of the knowledge acquired.
Filed in German · English published by the European Commission
Take this comparison with you
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.